Hong Kong Healthtech Stock News

Infinity Development Holdings (SEHK:640) just posted its FY 2025 results with second half revenue of HK$425.8 million and basic EPS of HK$0.233, backed by trailing 12 month revenue of HK$835.2 million and EPS of HK$0.434. The company has seen revenue move from HK$403.8 million in 2H FY 2024 to HK$425.8 million in 2H FY 2025, while half year EPS shifted from HK$0.211 to HK$0.233. The trailing 12 month EPS growth of 21.7% sits alongside net profit margins at 14.6%, compared with 13.6% a year...

WuXi Biologics recently achieved ISO 20400 Sustainable Procurement certification, an international standard that embeds sustainability, transparency, and responsibility into its procurement and supplier management practices. This certification highlights how WuXi Biologics has integrated sustainability across its supplier lifecycle, reinforcing supply chain resilience and its broader environmental, social, and governance profile. We will now examine how this new sustainable procurement...

In recent days, Tencent-backed initiatives have been in the spotlight, from China’s digital yuan pilot, where WeBank will pay quarterly interest subject to stricter identity checks, to Tencent-linked ETFs in emerging markets and portfolio companies like Airwallex and AI firm MiniMax expanding globally and listing in Hong Kong. Together, these developments highlight Tencent’s influence across digital finance, emerging markets exposure, and artificial intelligence, underlining how its...

Wondering if BYD's share price still lines up with its underlying worth, or if market sentiment has moved ahead of the fundamentals. BYD last closed at HK$95.30, with returns of a 0.1% decline over 7 days, a 4.0% decline over 30 days, a 3.5% decline year to date, but a 13.6% gain over 1 year, 35.9% over 3 years and 14.4% over 5 years, which hints at shifting risk and return perceptions over different timeframes. Recent coverage around BYD has focused on its role in the electric vehicle and...

Seyond Holdings (SEHK:2665), a Hong Kong based LiDAR producer for automotive use, has drawn investor attention after a recent daily gain of 2.8% alongside mixed short term share performance. See our latest analysis for Seyond Holdings. The HK$9.94 share price move today comes after a mixed few months, with a 30 day share price return of 3.64% and a year to date share price return of 3.96% decline. At the same time, the 1 year total shareholder return of 13.90% and 3 year total shareholder...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Key Insights The considerable ownership by retail investors in Genscript Biotech indicates that they collectively have...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...

Key Insights The considerable ownership by individual investors in Central China Securities indicates that they...

As we enter 2026, Asian markets are navigating a complex landscape, with China's manufacturing sector showing signs of recovery and Japan's stock market reflecting strong performances in technology and construction sectors. In this environment, growth companies with high insider ownership can be particularly appealing to investors seeking alignment between management interests and shareholder value.

As the Asian markets navigate a landscape marked by mixed performances in key indices, investors are increasingly looking toward niche opportunities for potential growth. Penny stocks, often associated with smaller or newer companies, continue to capture attention due to their potential for significant returns when backed by solid financials. Despite being an outdated term, these stocks provide a unique opportunity for discovering hidden value in quality companies that might be overlooked by...

As Asian markets navigate a mixed economic landscape, with China's manufacturing sector showing signs of recovery and South Korea's exports reaching new highs, investors are increasingly looking towards stable income-generating opportunities. In this context, dividend stocks can offer a reliable source of returns by providing consistent payouts, making them an attractive option for those seeking to balance growth with income in their portfolios.

Key Insights Using the 2 Stage Free Cash Flow to Equity, Hansoh Pharmaceutical Group fair value estimate is HK$52.95...

Key Insights Dmall's significant insider ownership suggests inherent interests in company's expansion 54% of the...

It is hard to get excited after looking at Zhongmiao Holdings (Qingdao)'s (HKG:1471) recent performance, when its stock...

It is hard to get excited after looking at Maiyue Technology's (HKG:2501) recent performance, when its stock has...

Key Insights The considerable ownership by private companies in Concord Healthcare Group indicates that they...

Beauty Farm Medical and Health Industry Inc. ( HKG:2373 ), might not be a large cap stock, but it saw a double-digit...

Key Insights Significant insider control over FWD Group Holdings implies vested interests in company growth Tzar Kai Li...

Key Insights Significant control over Clover Biopharmaceuticals by retail investors implies that the general public has...

Looking at Yidu Tech Inc.'s ( HKG:2158 ) insider transactions over the last year, we can see that insiders were net...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

Key Insights Significant control over Canggang Railway by individual investors implies that the general public has more...

When close to half the companies in the Consumer Retailing industry in Hong Kong have price-to-sales ratios (or "P/S...